TC
LLY icon

Trust Company’s Eli Lilly LLY Stock Holding History

Trust Company’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$592K Buy
512
+9
+2% +$10.6K 0.05% 93
2026
Q2 		$603K Sell
503
-1,929
-79% -$1.97M 0.05% 95
2026
Q1 		$2.24M Buy
2,432
+33
+1% +$33.5K 0.21% 51
2025
Q4 		$2.58M Buy
2,399
+1,952
+437% +$1.87M 0.24% 45
2025
Q3 		$341K Hold
447
– – 0.03% 111
2025
Q2 		$348K Hold
447
– – 0.04% 112
2025
Q1 		$369K Hold
447
– – 0.04% 105
2024
Q4 		$345K Hold
447
– – 0.04% 112
2024
Q3 		$396K Hold
447
– – 0.05% 100
2024
Q2 		$405K Sell
447
-3
-0.7% -$2.4K 0.05% 96
2024
Q1 		$350K Hold
450
– – 0.05% 97
2023
Q4 		$262K Buy
450
+422
+1,507% +$246K 0.03% 118
2023
Q3 		$15K Sell
28
-219
-89% -$113K ﹤0.01% 253
2023
Q2 		$116K Sell
247
-891
-78% -$374K 0.02% 157
2023
Q1 		$391K Sell
1,138
-30
-3% -$10.1K 0.06% 105
2022
Q4 		$427K Buy
1,168
+30
+3% +$10.6K 0.07% 100
2022
Q3 		$368K Sell
1,138
-4
-0.4% -$1.27K 0.08% 96
2022
Q2 		$370K Buy
1,142
+4
+0.4% +$1.2K 0.08% 100
2022
Q1 		$326K Hold
1,138
– – 0.06% 108
2021
Q4 		$314K Hold
1,138
– – 0.07% 95
2021
Q3 		$263K Hold
1,138
– – 0.07% 99
2021
Q2 		$261K Hold
1,138
– – 0.18% 93
2021
Q1 		$213K Hold
1,138
– – 0.15% 105
2020
Q4 		$192K Hold
1,138
– – 0.15% 106
2020
Q3 		$168K Hold
1,138
– – 0.14% 111
2020
Q2 		$187K Hold
1,138
– – 0.18% 96
2020
Q1 		$158K Hold
1,138
– – 0.17% 81
2019
Q4 		$150K Hold
1,138
– – 0.13% 102
2019
Q3 		$127K Hold
1,138
– – 0.12% 101
2019
Q2 		$126K Hold
1,138
– – 0.12% 104
2019
Q1 		$148K Hold
1,138
– – 0.09% 103
2018
Q4 		$132K Sell
1,138
-25
-2% -$2.79K 0.07% 92
2018
Q3 		$125K Sell
1,163
-150
-11% -$15K 0.06% 100
2018
Q2 		$112K Sell
1,313
-90
-6% -$7.39K 0.05% 113
2018
Q1 		$109K Hold
1,403
– – 0.04% 115
2017
Q4 		$118K Hold
1,403
– – 0.05% 102
2017
Q3 		$120K Sell
1,403
-200
-12% -$16.4K 0.07% 91
2017
Q2 		$132K Sell
1,603
-105
-6% -$8.57K 0.06% 104
2017
Q1 		$144K Hold
1,708
– – 0.07% 113
2016
Q4 		$126K Hold
1,708
– – 0.06% 117
2016
Q3 		$137K Hold
1,708
– – 0.06% 126
2016
Q2 		$135K Hold
1,708
– – 0.05% 125
2016
Q1 		$123K Hold
1,708
– – 0.06% 124
2015
Q4 		$144K Sell
1,708
-81
-5% -$6.72K 0.07% 106
2015
Q3 		$150K Buy
1,789
+549
+44% +$46.3K 0.09% 95
2015
Q2 		$104K Buy
1,240
+100
+9% +$7.62K 0.07% 142
2015
Q1 		$83K Buy
+1,140
New +$81.2K 0.05% 134

Other funds holding LLY

SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return

Trust Company's LLY Position: Q3 2026 in Review

Trust Company increased its Eli Lilly (LLY) stake by 1.8% in Q3 2026, buying an estimated $10.6K and bringing the position to 512 shares worth $592K. The position accounts for 0.05% of the portfolio, ranked #93.

Trust Company first reported a position in LLY in Q1 2015 and has held it in 47 quarters since. The position peaked at $2.58M in Q4 2025. 255 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Trust Company held 512 shares of Eli Lilly worth $592K as of Q3 2026.
  • Trust Company bought 9 Eli Lilly shares in Q3 2026, an estimated $10.6K.
  • Eli Lilly made up 0.05% of Trust Company's portfolio in Q3 2026, its #93 holding.
  • Trust Company first reported a position in Eli Lilly in Q1 2015 and has held it in 47 quarters since.
  • Trust Company's Eli Lilly position peaked at $2.58M in Q4 2025.
  • 255 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Trust Company's 13F filing for Q3 2026, filed 9 Oct 2026.